{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T18:22:19Z","timestamp":1792347739179,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T00:00:00Z","timestamp":1380067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s12640-013-9425-0","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T01:17:09Z","timestamp":1380071829000},"page":"323-334","source":"Crossref","is-referenced-by-count":17,"title":["1-Methyl-1,2,3,4-tetrahydroisoquinoline, an Endogenous Neuroprotectant and MAO Inhibitor with Antidepressant-Like Properties in the Rat"],"prefix":"10.1007","volume":"25","author":[{"given":"Agnieszka","family":"W\u0105sik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Mo\u017cd\u017ce\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Michaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Roma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Antkiewicz-Michaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,25]]},"reference":[{"key":"9425_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0924-977X(99)00048-6","volume":"10","author":"JC Alvarez","year":"1999","unstructured":"Alvarez JC, Sanceaume M, Advenier C, Spreux-Varoquaux O (1999) Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice. Eur Neuropsychopharmacol 10:31\u201336","journal-title":"Eur Neuropsychopharmacol"},{"key":"9425_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jad.2012.03.007","volume":"141","author":"JD Amsterdam","year":"2012","unstructured":"Amsterdam JD, Newberg AB, Soeller I, Shults J (2012) Greater striatal dopamine transporter density may be associated with major depressive episode. J Affect Disord 141:425\u2013431","journal-title":"J Affect Disord"},{"key":"9425_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1471-4159.2001.00391.x","volume":"78","author":"L Antkiewicz-Michaluk","year":"2001","unstructured":"Antkiewicz-Michaluk L, Michaluk J, Mokrosz M, Roma\u0144ska I, Lorenc-Koci E, Otha S, Vetulani J (2001) Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. J Neurochem 78:100\u2013108","journal-title":"J Neurochem"},{"issue":"3","key":"9425_CR4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2006.03756.x","volume":"97","author":"L Antkiewicz-Michaluk","year":"2006","unstructured":"Antkiewicz-Michaluk L, \u0141azarewicz JW, Patsenka A, Kajta M, Ziemi\u0144ska E, Sali\u0144ska E, W\u0105sik A, Golembiowska K, Vetulani J (2006) The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properities and inhibition of glutamate-induced excitotoxicity. J Neurochem 97(3):846\u2013856","journal-title":"J Neurochem"},{"key":"9425_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(88)90068-4","volume":"158","author":"A Antonio","year":"1988","unstructured":"Antonio A, Gavalda A, Marti O (1988) Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior swimming, immobility and defecation rate. Eur J Pharmacol 158:207\u2013212","journal-title":"Eur J Pharmacol"},{"key":"9425_CR6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","volume":"311","author":"O Berton","year":"2006","unstructured":"Berton O, MCClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864\u2013868","journal-title":"Science"},{"issue":"3","key":"9425_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0091-3057(03)00110-2","volume":"75","author":"SK Bhattacharya","year":"2003","unstructured":"Bhattacharya SK, Muruganandam AV (2003) Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 75(3):547\u2013555","journal-title":"Pharmacol Biochem Behav"},{"issue":"2\u20133","key":"9425_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","volume":"91","author":"AS Brown","year":"1993","unstructured":"Brown AS, Gershon S (1993) Dopamine and depression. J Neural Transm Gen Sect 91(2\u20133):75\u2013109","journal-title":"J Neural Transm Gen Sect"},{"key":"9425_CR9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0278-5846(98)00106-7","volume":"23","author":"CE Byrum","year":"1999","unstructured":"Byrum CE, Ahearn EP, Krishnan KR (1999) A neuroanatomic model for depression. Prog Neuropsychopharmacol Biol Psychiatry 23:175\u2013193","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9425_CR10","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1523\/JNEUROSCI.1758-09.2009","volume":"29","author":"HE Covington","year":"2009","unstructured":"Covington HE, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29:11451\u201311460","journal-title":"J Neurosci"},{"key":"9425_CR11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","volume":"295","author":"JF Cryan","year":"2000","unstructured":"Cryan JF, Lucki I (2000) Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther 295:1120\u20131126","journal-title":"J Pharmacol Exp Ther"},{"key":"9425_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","volume":"182","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Page ME, Lucki I (2005) Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacol 182:335\u2013344","journal-title":"Psychopharmacol"},{"key":"9425_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","volume":"73","author":"MJ Detke","year":"1996","unstructured":"Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43\u201346","journal-title":"Behav Brain Res"},{"key":"9425_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotoninergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66\u201372","journal-title":"Psychopharmacol (Berl)"},{"key":"9425_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1037\/1064-1297.5.2.107","volume":"5","author":"MJ Detke","year":"1997","unstructured":"Detke MJ, Johnson J, Lucki I (1997) Acute and chronic antidepressant drug treatment in the rat forced swimming test model depression. Exp Clin Psychopharmacol 5:107\u2013112","journal-title":"Exp Clin Psychopharmacol"},{"key":"9425_CR17","doi-asserted-by":"crossref","unstructured":"Dykens JA (1999) Free radicals and mitochondria dysfunction in excitotoxicity and neurodegenerative disease. In: Cell death and diseases of the nervous system. Humana Press, Totowa, pp 45\u201368","DOI":"10.1007\/978-1-4612-1602-5_3"},{"key":"9425_CR18","first-page":"625","volume":"58","author":"M Filip","year":"2007","unstructured":"Filip M, Antkiewicz-Michaluk L, Zaniewska M, Frankowska M, Go\u0142da A, Vetulani J, Przegali\u0144ski E (2007) Effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the behavioral effects of cocaine in rats. J Physiol Pharmacol 58:625\u2013639","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"9425_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-2952(79)90108-4","volume":"28","author":"GL Grunewald","year":"1979","unstructured":"Grunewald GL, Reitz TJ, Ruth JA, Vollmer S, Eiden LE, Rutledge CO (1979) Inhibition of neuronal uptake of 3H-biogenic amines into rat cerebral cortex by partially and fully saturated derivatives of imipramine and desipramine. The importance of the aromatic ring in adrenergic amines-part 3. Biochem Pharmacol 28(3):417\u2013421","journal-title":"Biochem Pharmacol"},{"key":"9425_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02246225","volume":"106","author":"W Haefely","year":"1992","unstructured":"Haefely W, Burkard WP, Cesura AM, Kettler R, Lorez HP, Martin JR, Richards JG, Scherschlicht R, Da Prada M (1992) Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology 106:6\u201314","journal-title":"Psychopharmacology"},{"key":"9425_CR21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1615\/CritRevNeurobiol.v15.i2.30","volume":"15","author":"PV Holmes","year":"2003","unstructured":"Holmes PV (2003) Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol 15:143\u2013174","journal-title":"Crit Rev Neurobiol"},{"issue":"1","key":"9425_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0024-3205(79)90275-3","volume":"24","author":"JI Javaid","year":"1979","unstructured":"Javaid JI, Perel JM, Davis JM (1979) Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain. Life Sci 24(1):21\u201328","journal-title":"Life Sci"},{"key":"9425_CR23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jnr.20754","volume":"83","author":"KS Kim","year":"2006","unstructured":"Kim KS, Han PL (2006) Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J Neurosci Res 83:497\u2013507","journal-title":"J Neurosci Res"},{"key":"9425_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainres.2010.05.097","volume":"1348","author":"SY Kim","year":"2010","unstructured":"Kim SY, Lee YJ, Kim H, Lee DW, Woo DC, Choi CB, Chae JH, Choe BY (2010) Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: An in vivo 1H-MRS study at 9.4T. Brain Res 1348:105\u2013113","journal-title":"Brain Res"},{"key":"9425_CR25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5607\/en.2012.21.1.16","volume":"21","author":"KS Kim","year":"2012","unstructured":"Kim KS, Kwon HJ, Baek IS, Han PL (2012) Repeated short-term (2h\u00d714d) emotional stress induces lasting depression-like behavior in mice. Exp Neurobiol 21:16\u201322","journal-title":"Exp Neurobiol"},{"issue":"4","key":"9425_CR26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1254\/jphs.FP0072150","volume":"106","author":"Y Kitamura","year":"2008","unstructured":"Kitamura Y, Kitagawa K, Kimoto S, Sagara H, Shibata K, Kawasaki H, Sendo T, Gomita Y (2008) Selegilin exerts antidepressant-like effects during the forced swim test in adrenocorticotropic hormone-treated rats. J Pharmacol Sci 106(4):639\u2013644","journal-title":"J Pharmacol Sci"},{"key":"9425_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","volume":"155","author":"I Lucki","year":"2001","unstructured":"Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155:315\u2013322","journal-title":"Psychopharmacology"},{"key":"9425_CR28","first-page":"313","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M, Mihaylova I, Kubera M, Leunis JC (2008) An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS. Neuro Endocrinol Lett 29:313\u2013319","journal-title":"Neuro Endocrinol Lett"},{"key":"9425_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","volume":"24","author":"M Maes","year":"2009","unstructured":"Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M (2009) The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24:27\u201353","journal-title":"Metab Brain Dis"},{"issue":"2","key":"9425_CR30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0091-3057(95)02019-5","volume":"53","author":"H Miura","year":"1996","unstructured":"Miura H, Naoi M, Nakahara D, Ohta T, Nagatsu T (1996) Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice. Pharmacol Biochem Behav 53(2):469\u2013475","journal-title":"Pharmacol Biochem Behav"},{"key":"9425_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MNM.0b013e328013dc9d","volume":"28","author":"AB Newberg","year":"2007","unstructured":"Newberg AB, Amsterdam JD, Shults J (2007) Dopamine transporter density may be associated with the depressed affect in the healthy subjects. Nucl Med Commun 28:3\u20136","journal-title":"Nucl Med Commun"},{"key":"9425_CR32","first-page":"727","volume":"56","author":"A Patsenka","year":"2004","unstructured":"Patsenka A, Antkiewicz-Michaluk L (2004) Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds\u20141,2,3,4-tetrahydro-isoquinoline alkaloids. Pol J Pharmacol 56:727\u2013734","journal-title":"Pol J Pharmacol"},{"key":"9425_CR33","first-page":"179","volume":"56","author":"A Patsenka","year":"2004","unstructured":"Patsenka A, Go\u0142embiowska K, Ziemi\u0144ska E, Sali\u0144ska E, \u0141azarewicz J, W\u0105sik A, Michaluk J, Antkiewicz-Michaluk L (2004) Neuroprotective effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline: in vitro and in vivo studies in rats. Pol J Pharmacol 56:179\u2013180","journal-title":"Pol J Pharmacol"},{"key":"9425_CR34","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioural despair test in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn 229:327\u2013336","journal-title":"Arch Int Pharmacodyn"},{"key":"9425_CR35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair test in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391","journal-title":"Eur J Pharmacol"},{"key":"9425_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(96)00772-8","volume":"318","author":"JP Redrobe","year":"1996","unstructured":"Redrobe JP, MacSweeney CP, Bourin M (1996) The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur J Pharmacol 318:213\u2013220","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"9425_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1472-8206.2003.00160.x","volume":"17","author":"CE Renard","year":"2003","unstructured":"Renard CE, Dailly E, David DJ, Hascoet M, Bourin M (2003) Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 17(4):449\u2013455","journal-title":"Fundam Clin Pharmacol"},{"key":"9425_CR38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(98)00126-9","volume":"47","author":"MA Rogers","year":"1998","unstructured":"Rogers MA, Bradshaw JL, Pantelis C, Philips JG (1998) Frontostriatal deficits in unipolar major depression. Brain Res Bull 47:297\u2013310","journal-title":"Brain Res Bull"},{"key":"9425_CR39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/11633190-000000000-00000","volume":"26","author":"G Scapagnini","year":"2012","unstructured":"Scapagnini G, Davinelli S, Drago F, De Lorenzo A, Oriani G (2012) Antioxidants as antidepressants: fact or fiction? CNS Drugs 26:477\u2013490","journal-title":"CNS Drugs"},{"key":"9425_CR40","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1017\/S0033291797005382","volume":"27","author":"PJ Shah","year":"1997","unstructured":"Shah PJ, Ogilvie AD, Goodwin GM, Ebmeier KP (1997) Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med 27:1247\u20131256","journal-title":"Psychol Med"},{"key":"9425_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","volume":"4","author":"DF Swaab","year":"2005","unstructured":"Swaab DF, Bao AM, Lucassen PJ (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4:141\u2013194","journal-title":"Ageing Res Rev"},{"issue":"4","key":"9425_CR42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nn1659","volume":"9","author":"NM Tsankova","year":"2006","unstructured":"Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9(4):519\u2013525","journal-title":"Nat Neurosci"},{"key":"9425_CR43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03033379","volume":"5","author":"J Vetulani","year":"2003","unstructured":"Vetulani J, Antkiewicz-Michaluk L, Nalepa I, Sansone M (2003) A possible physiological role for cerebral tetrahydroisoquinolines. Neurotox Res 5:147\u2013156","journal-title":"Neurotox Res"},{"key":"9425_CR44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12264-010-0329-1","volume":"26","author":"SS Wang","year":"2010","unstructured":"Wang SS, Yan XB, Hofman MA, Swaab DF, Zhou JN (2010) Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats expose to chronic unpredictable mild stress. Neurosci Bull 26:297\u2013303","journal-title":"Neurosci Bull"},{"key":"9425_CR45","first-page":"235","volume":"58","author":"A W\u0105sik","year":"2007","unstructured":"W\u0105sik A, Roma\u0144ska I, Antkiewicz-Michaluk L (2007) The effect of an endogenous compoud 1-methyl-1,2,3,4-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures. J Physiol Pharmacol 58:235\u2013252","journal-title":"J Physiol Pharmacol"},{"key":"9425_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2012.11.063","volume":"700","author":"A W\u0105sik","year":"2013","unstructured":"W\u0105sik A, Mo\u017cd\u017ce\u0144 E, Roma\u0144ska I, Michaluk J, Antkiewicz-Michaluk L (2013) Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: a comparison with the classical antidepressant, imipramine. Eur J Pharmacol 700:110\u2013117","journal-title":"Eur J Pharmacol"},{"key":"9425_CR47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4088\/JCP.v57n1206","volume":"57","author":"BA Wroblewski","year":"1996","unstructured":"Wroblewski BA, Joseph AB, Cornblatt RR (1996) Antidepressant pharmacotherapy and the treatment of depression in the patients with severe traumatic brain injury: a controlled, prospective study. J Clin Psychiatry 57:582\u2013587","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"9425_CR48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0304-3940(99)00786-7","volume":"276","author":"T Yamakawa","year":"1999","unstructured":"Yamakawa T, Kotake Y, Fuijtani M, Shintani H, Makino Y, Otha S (1999) Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain. Neurosci Lett 276(1):68\u201370","journal-title":"Neurosci Lett"},{"key":"9425_CR49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjp.0706464","volume":"147","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br J Pharmacol 147:287\u2013296","journal-title":"Br J Pharmacol"},{"key":"9425_CR50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295\u2013309","journal-title":"Nat Rev Neurosci"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-013-9425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-013-9425-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-013-9425-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:53:55Z","timestamp":1746024835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-013-9425-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,25]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["9425"],"URL":"https:\/\/doi.org\/10.1007\/s12640-013-9425-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,25]]}}}